4-CHLOROMETHYL-2-(2-METHOXY-PHENYL)-5-METHYL-OXAZOLE
|
- $134 - $2383
- Product name: 4-CHLOROMETHYL-2-(2-METHOXY-PHENYL)-5-METHYL-OXAZOLE
- CAS: 475481-99-3
- MF: C12H12ClNO2
- MW: 237.68
- EINECS:
- MDL Number:MFCD08457264
- Synonyms:4-CHLOROMETHYL-2-(2-METHOXY-PHENYL)-5-METHYL-OXAZOLE;4-(Chloromethyl)-2-(2-methoxyphenyl)-5-methyl-1,3-oxazole;Oxazole, 4-(chloromethyl)-2-(2-methoxyphenyl)-5-methyl-
3 prices
Selected condition:
Brand
- American Custom Chemicals Corporation
- Labseeker
- Sigma-Aldrich
Package
- 5MG
- 1g
- 10g
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberHCH0046917
- Product description4-(CHLOROMETHYL)-2-(2-METHOXYPHENYL)-5-METHYLOXAZOLE 95.00%
- Packaging5MG
- Price$500.85
- Updated2021-12-16
- Buy
- ManufacturerLabseeker
- Product numberSC-32228
- Product description4-(CHLOROMETHYL)-2-(2-METHOXYPHENYL)-5-METHYLOXAZOLE 95
- Packaging10g
- Price$2383
- Updated2021-12-16
- Buy
- ManufacturerSigma-Aldrich
- Product numberPH017489
- Product description4-(Chloromethyl)-2-(2-methoxyphenyl)-5-methyl-1,3-oxazole AldrichCPR
- Packaging1g
- Price$134
- Updated2023-06-20
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| American Custom Chemicals Corporation | HCH0046917 | 4-(CHLOROMETHYL)-2-(2-METHOXYPHENYL)-5-METHYLOXAZOLE 95.00% | 5MG | $500.85 | 2021-12-16 | Buy |
| Labseeker | SC-32228 | 4-(CHLOROMETHYL)-2-(2-METHOXYPHENYL)-5-METHYLOXAZOLE 95 | 10g | $2383 | 2021-12-16 | Buy |
| Sigma-Aldrich | PH017489 | 4-(Chloromethyl)-2-(2-methoxyphenyl)-5-methyl-1,3-oxazole AldrichCPR | 1g | $134 | 2023-06-20 | Buy |
Properties
form :solid
Safety Information
| Symbol(GHS): |
![]()
|
||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal word: | Warning | ||||||||||||||||||||||||||||||||||||||||||
| Hazard statements: |
|
||||||||||||||||||||||||||||||||||||||||||
| Precautionary statements: |
|





